论文部分内容阅读
血清相关肿瘤标志物的检测是一种快速、微创、可重复操作的检验方法,是乳腺癌术后随访监测疗效的重要手段[1]。本文测定乳腺癌患者血清CA15-3、CEA和CA-125水平,统计分析其与乳腺癌各种临床病理因素以及病情转归的关系,进一步明确其在乳腺癌术后随访监测中的价值。1资料与方法1.1一般资料选取我院于2012年2月至2013年3月间收治的女性乳腺癌患者完整病例219例,并对219
Serum-related tumor markers detection is a fast, minimally invasive, repeatable test method, is an important means of follow-up monitoring of breast cancer [1]. This article measured serum CA15-3, CEA and CA-125 levels in patients with breast cancer, and statistical analysis of its relationship with various clinicopathological factors and prognosis of breast cancer to further clarify its value in postoperative follow-up monitoring of breast cancer. 1 Materials and Methods 1.1 General Information Select our hospital from February 2012 to March 2013 were admitted to the 219 cases of complete breast cancer patients, and 219